Literature DB >> 23649769

Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.

Fernanda Magri de Carvalho1, Thiago de Almeida Pereira, Patrícia Lofego Gonçalves, Robson Dettmann Jarske, Fausto Edmundo Lima Pereira, Iuri Drumond Louro.   

Abstract

The close relationship between aflatoxins and 249ser TP53 gene mutation (AGG to AGT, Arg to Ser) in hepatocellular carcinoma (HCC) makes this mutation an indirect indicator of dietary contamination with this toxin. We have examined the prevalence of codon 249 TP53 mutation in 41 HCC and 74 liver cirrhosis (without HCC) cases diagnosed at the HUCAM University Hospital in Vitoria, Espírito Santo State, Brazil. DNA was extracted from paraffin sections and from plasma. The mutation was detected by DNA amplification, followed by restriction endonuclease digestion and confirmed by direct sequencing. DNA restriction showed 249ser mutation in 16 HCC and 13 liver cirrhosis, but sequencing confirmed mutations in only 6 HCC and 1 liver cirrhosis. In addition, sequencing revealed 4 patients with mutations at codon 250 (250ser and 250leu) in HCC cases. The prevalence of TP53 mutation was 10/41 (24.3%) in HCC and 1/74 (1.4%) in liver cirrhosis. No relationship between the presence of mutations and the etiology of HCC was observed. TP53 exon 7 mutations, which are related to aflatoxins exposure, were found at 14.6% (249ser), 7.3% (250leu) and 2.4% (250ser) in 41 cases of HCC and 1.4% in 74 liver cirrhosis (without HCC) cases, suggesting a moderate dietary exposure to aflatoxins in the Espírito Santo State, Brazil.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649769     DOI: 10.1007/s11033-013-2587-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

1.  Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.

Authors:  G D Kirk; A M Camus-Randon; M Mendy; J J Goedert; P Merle; C Trépo; C Bréchot; P Hainaut; R Montesano
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

2.  p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.

Authors:  R M Lunn; Y J Zhang; L Y Wang; C J Chen; P H Lee; C S Lee; W Y Tsai; R M Santella
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

3.  249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.

Authors:  Gerald C Kimbi; Michael C Kew; Mimi C Yu; Kazuko Arakawa; John Hodkinson
Journal:  J Gastroenterol Hepatol       Date:  2005-08       Impact factor: 4.029

Review 4.  Hepatocellular carcinoma: A global view.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

5.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

6.  249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.

Authors:  Gregory D Kirk; Olufunmilayo A Lesi; Maimuna Mendy; Katarzyna Szymañska; Hilton Whittle; James J Goedert; Pierre Hainaut; Ruggero Montesano
Journal:  Oncogene       Date:  2005-09-01       Impact factor: 9.867

7.  Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.

Authors:  M F Denissenko; J Cahill; T B Koudriakova; N Gerber; G P Pfeifer
Journal:  Mutat Res       Date:  1999-04-06       Impact factor: 2.433

Review 8.  Hepatocellular carcinoma: from gene to public health.

Authors:  R Montesano; P Hainaut; C P Wild
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

9.  An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.

Authors:  Y Soini; S C Chia; W P Bennett; J D Groopman; J S Wang; V M DeBenedetti; H Cawley; J A Welsh; C Hansen; N V Bergasa; E A Jones; A M DiBisceglie; G E Trivers; C A Sandoval; I E Calderon; L E Munoz Espinosa; C C Harris
Journal:  Carcinogenesis       Date:  1996-05       Impact factor: 4.944

10.  High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.

Authors:  P Coursaget; N Depril; M Chabaud; R Nandi; V Mayelo; P LeCann; B Yvonnet
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  2 in total

Review 1.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

2.  Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.

Authors:  Joshua W Smith; Maria F Kroker-Lobos; Mariana Lazo; Alvaro Rivera-Andrade; Patricia A Egner; Heiner Wedemeyer; Olga Torres; Neal D Freedman; Katherine A McGlynn; Eliseo Guallar; John D Groopman; Manuel Ramirez-Zea
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.